Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials with Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors

Lassman, A. B., Hoang-Xuan, K., Polley, M.-Y. C., Brandes, A. A., Cairncross, J. G., Kros, J. M., Ashby, L. S., Taphoorn, M. J. B., Souhami, L., Dinjens, W. N. M., Laack, N. N., Kouwenhoven, M. C. M., Fink, K. L., French, P. J., Macdonald, D. R., Lacombe, D., Won, M., Gorlia, T., Mehta, M. P., & van den Bent, M. J. (2022). Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. Journal of Clinical Oncology, 40(23), 2539–2545. https://doi.org/10.1200/jco.21.02543
Authors:
Andrew B. Lassman
Khê Hoang-Xuan
Mei-Yin C. Polley
Alba A. Brandes
J. Gregory Cairncross
Johan M. Kros
Lynn S. Ashby
Martin J.B. Taphoorn
Luis Souhami
Winand N.M. Dinjens
Nadia N. Laack
Mathilde C.M. Kouwenhoven
Karen L. Fink
Pim J. French
David R. Macdonald
Denis Lacombe
Minhee Won
Thierry Gorlia
Minesh P. Mehta
Martin J. Van Den Bent
Affiliated Authors:
Andrew B. Lassman
Subjects:
Publication Type:
Article
Unique ID:
10.1200/JCO.21.02543
PMID:
Publication Date:
Data Source:
Scopus

Record Created: